Increased risk of venous thromboembolism with a sirolimus-based immunosuppression regimen in lung transplantation.
Ahya VN, McShane PJ, Baz MA, Valentine VG, Arcasoy SM, Love RB, Seethamraju H, Garrity E, Alex CG, Bag R, DeOliveira NC, Vigneswaran WT, Charbeneau J, Krishnan JA, Durazo-Arvizu R, Norwick L, Bhorade S.
Ahya VN, et al. Among authors: bhorade s.
J Heart Lung Transplant. 2011 Feb;30(2):175-81. doi: 10.1016/j.healun.2010.08.010. Epub 2010 Oct 13.
J Heart Lung Transplant. 2011.
PMID: 20947384
Clinical Trial.